← FDA Drug Approvals (Drugs@FDA)
BROMOCRIPTINE MESYLATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: PADAGIS US · Approved 2008-10-01
Drug application
- FDA Application #
ANDA077646- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- BROMOCRIPTINE MESYLATE
- Generic name
- BROMOCRIPTINE MESYLATE
- Active ingredients
- BROMOCRIPTINE MESYLATE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- PADAGIS US
- Manufacturer
- Padagis US LLC
- First approval
- 2008-10-01
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown